Surrozen, Inc. Common (SRZN)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$30.08−$3.60 (−10.69%) on the dayAs of the close; data may be delayed.
SRZN price, last 12 months
Key stats
- Previous close
- $33.68
- Open
- $31.39
- Day range
- $28.55 – $37.83
- 52-week range
- $11.39 – $37.83
- Volume
- 1.9M
- Avg volume (20 days)
- 829.8K
- Market cap
- $347.2M
Performance
1W+81.8%
1M+26.9%
3M+19.3%
6M+7.4%
YTD+33.1%
1Y+156.0%
vs S&P 500, 1Y+139.2 pts
Technicals and fundamentals
About Surrozen, Inc. Common
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $347.2M